Imagen de Portada

Editorial: Seton Use in Perianal Fistulising Crohn's Disease. Authors' Reply

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Jeffrey D McCurdy, Blair Macdonald, Greg Rosenfeld, Talat Bessissow, Vipul Jairath, David H. Bruining, Siddharth Singh
Formato:	Artículo Open Access
Publicado:	Wiley 2025
Materias:	Alimentary Pharmacology & Therapeutics
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Letter: Re‐Examining Seton Efficacy in Perianal Crohn's Disease—Critical Considerations for Outcome Measurement and Clinical Interpretation. Authors' Reply
por: Jeffrey D. McCurdy, et al.
Publicado: (2025)

Editorial: Mesenchymal Stem Cell Therapy for Perianal Fistulising Crohn's Disease—Effective or Hype?
por: Jeffrey D McCurdy, et al.
Publicado: (2024)

Systematic Review of Published Guidelines: Recommendations for Exams Under Anaesthesia, Seton Insertion and Timing of Seton Removal for Perianal and Rectovaginal Fistulising Crohn's Disease
por: Edgard Medawar, et al.
Publicado: (2026)

Letter: Bowel Preparation Quality in Patients With Crohn's Disease—Authors' Reply
por: Virginia Solitano, et al.
Publicado: (2024)

Editorial: Fistula Calprotectin as a Biomarker of Local Inflammation and Treatment Response in Perianal Fistulising Crohn's Disease. Authors' Reply
por: Runqi Wang, et al.
Publicado: (2026)

Editorial: The Devil Is in the Detail—Interpreting the Findings of Network Meta‐Analyses. Authors' Reply
por: Mohammad Shehab, et al.
Publicado: (2025)

Editorial: Examining Perianal Fistulising Crohn's Disease Through the Lens of Wound Repair
por: Tim Eglinton
Publicado: (2025)

Letter: Re‐Examining Seton Efficacy in Perianal Crohn's Disease—Considerations for Outcome Measurement and Clinical Interpretation
por: Dingsheng Liu, et al.
Publicado: (2025)

Network Meta‐Analysis: Comparative Efficacy of Biologics and Small Molecules in the Induction and Maintenance of Remission in Crohn's Disease
por: Mohammad Shehab, et al.
Publicado: (2025)

Editorial: Upadacitinib in Perianal Crohn's Disease
por: Manjeet Kumar Goyal, et al.
Publicado: (2026)

Correction to ‘Stromal Vascular Fraction With Platelet‐Rich Plasma Injection During Surgery is Feasible and Safe in Treatment‐Refractory Perianal Fistulising Crohn's Disease: A Pilot Study’
Publicado: (2024)

Editorial: Development and Validation of a Multimodal Machine Learning Model for Diagnosing and Assessing Risk of Crohn's Disease in Patients With Perianal Fistulae: Authors' Reply
por: Lichao Qiao, et al.
Publicado: (2025)

Letter: Real‐Life Evaluation of Effectiveness of Mesenchymal Stem Cell Treatment in Fistulising Crohn's Disease Emphasises Importance of Appropriate Patient Selection and Centre Expertise—Authors' Reply
por: Péter Bacsur, et al.
Publicado: (2024)

Editorial: Beyond Resection—Rethinking Postoperative Management in Colonic Crohn's Disease. Authors' Reply
por: José Luis Rueda García, et al.
Publicado: (2026)

One‐Year Effectiveness of Upadacitinib in Perianal Crohn's Disease: A Real‐World GETAID Study
por: Nicolas Richard, et al.
Publicado: (2026)

Fistula Calprotectin as a Biomarker of Local Inflammation and Treatment Response in Perianal Fistulizing Crohn's Disease
por: Runqi Wang, et al.
Publicado: (2026)

Editorial: Real‐World Evidence of Upadacitinib—An Effective Induction Therapy for Crohn's Disease? Authors' Reply
por: Nicolas Richard, et al.
Publicado: (2025)

Evaluation of the Effectiveness and Safety of Mesenchymal Stem Cell Treatment in Fistulising Crohn's Disease: An International Real‐Life Retrospective Multicentre Cohort Study
por: Péter Bacsur, et al.
Publicado: (2024)

Editorial: Foretelling the future—Emerging role of magnetic resonance enterography as a prognostic tool in Crohn's disease
por: Siri A. Urquhart, et al.
Publicado: (2024)

Letter: Real‐Life Evaluation of Effectiveness of Mesenchymal Stem Cell Treatment in Fistulising Crohn's Disease Emphasises the Importance of Appropriate Patient Selection and Centre Expertise
por: Weilun Gao, et al.
Publicado: (2024)

Letter: Early Ileal Resection in Crohn's Disease Is Not Associated With Severe Long‐Term Outcomes: The ERIC Study: Authors' Reply
por: Nathan Grellier, et al.
Publicado: (2025)

Letter: Putting Crohn's Risk Prediction to Work in Perianal Fistula—Calibration, Thresholds, and Transport
por: Emmanuel Pio Pastore
Publicado: (2025)

Editorial: Development and Validation of a Multimodal Machine Learning Model for Diagnosing and Assessing Risk of Crohn's Disease in Patients With Perianal Fistula
por: Alyssa M. Parian, et al.
Publicado: (2025)

Letter: Early Inflammatory Benefit Is Not Yet Equivalent to Durable Surgical Advantage After Colectomy in Colonic Crohn's Disease. Authors' Reply
por: José Luis Rueda García, et al.
Publicado: (2026)

Editorial: Intestinal Ultrasound for the Assessment of Constipation—Out of the Shadows? Authors' Reply
por: Ryan M. Mathias, et al.
Publicado: (2025)

Overall and Comparative Risk of Shingles With Advanced Therapies in Patients With Inflammatory Bowel Diseases
por: Dhruv Ahuja, et al.
Publicado: (2025)

Systematic Review: Ultrasound Goes Echo—Decarbonising Inflammatory Bowel Disease Care Through Intestinal Ultrasound
por: Sara Massironi, et al.
Publicado: (2025)

Editorial: Allostatic Load and Inflammatory Bowel Disease. Authors' Reply
por: Jianhui Zhao, et al.
Publicado: (2024)

Systematic review: Defining, diagnosing and monitoring small bowel strictures in Crohn's disease on intestinal ultrasound
por: Cathy Lu, et al.
Publicado: (2024)

Editorial: Can We Prevent Inflammatory Bowel Disease? Authors' Reply
por: Fai Fai Ho, et al.
Publicado: (2025)

Editorial: The Hidden Burden—Stigmatisation in Inflammatory Bowel Disease: Authors' Reply
por: Suprabhat Giri, et al.
Publicado: (2025)

Editorial: Revolutionising Steatotic Liver Disease Diagnosis With Phosphatidylethanol—Authors' Reply
por: Federica Tavaglione, et al.
Publicado: (2025)

Editorial: Are Antidepressant Medications Safe in Inflammatory Bowel Disease? Authors' Reply
por: Bharati Kochar, et al.
Publicado: (2025)

Performance of bowel preparation quality scales in patients with Crohn's disease
por: Virginia Solitano, et al.
Publicado: (2024)

Editorial: Prevalence of Suspected Metabolic Dysfunction‐Associated Liver Disease in Adolescents in the United States Using Updated Diagnostic Criteria—Authors' Reply
por: Sheila L. Noon, et al.
Publicado: (2025)

Letter: Optimising Hepatitis B Vaccination in Inflammatory Bowel Disease – Expanding Strategies Beyond Double‐Dose Recombinant Vaccination. Authors' Reply
por: Anupam Kumar Singh, et al.
Publicado: (2026)

Letter: Zinc and Selenium—Potential Biomarkers for Chronic Liver Disease? Authors' Reply
por: Nina Dominik, et al.
Publicado: (2024)

Meta‐Analysis: Improvement of Bowel Urgency With Advanced Therapies for Inflammatory Bowel Disease
por: Purab Patel, et al.
Publicado: (2025)

Editorial: Can We Modify the Development and Disease Course of Inflammatory Bowel Disease by Diet? Author's Reply
por: Aurelien Amiot, et al.
Publicado: (2025)

Editorial: Inflammatory Bowel Disease and Dietary Emulsifiers—A Conundrum That Continues. Authors' Reply
por: Jessica A. Fitzpatrick, et al.
Publicado: (2025)